^
Association details:
| Biomarker: | SERPINH1 overexpression |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug: | vinorelbine tartrate (Tubulin polymerization inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
Published date:
12/30/2022
Excerpt:
We also analyzed the common clinical anti-tumor drugs and the results showed that the 8 common anti-tumor drugs (i.e., cyclopamine, etoposide, lapatinib, paclitaxel, vinorelbine, sunitinib, doxorubicin, and midostaurin) were more effective in the IC50 of the SERPINH1 high expression group was significantly lower than that of the low expression group...This suggests that anti-tumor therapy was more efficacious in the SERPINH1 high-expression group than the SERPINH1 low-expression group.
DOI:
10.21037/jtd-22-1518
